Ocular Surface Disease
Conditions
Keywords
ocular surface disease, eye care, pediatric intensive care, nursing, artificial tears, saline
Brief summary
The primary aim of this study is to comparatively examine the effects of eye care practices using artificial tears and normal saline on superficial ocular injuries in pediatric patients receiving mechanical ventilation in the intensive care unit. Based on the findings, the study seeks to provide evidence-based contributions to nursing practices. Additionally, it aims to identify educational strategies to enhance intensive care nurses' knowledge and practice levels and to support the development of clinical care protocols. H0: There is no difference in the effect of eye care with normal saline and artificial tears on superficial ocular injury in mechanically ventilated pediatric patients. H1:Eye care with normal saline is more effective than artificial tears in preventing superficial ocular injury in mechanically ventilated pediatric patients. H2: Eye care with artificial tears is more effective than normal saline in preventing superficial ocular injury in mechanically ventilated pediatric patients.
Interventions
OTHEREye Care with Artificial Tears
Every 2 hours, the artificial tear solution was gently applied to the designated eye for 5 days. The artificial tear product (REFRESH®) contains 5.6 mg of polyvinyl alcohol and 2.4 mg of povidone per mL and is used to maintain ocular surface moisture and reduce irritation.
OTHEREye Care with Normal Saline
Every 2 hours, the saline solution(Bio-Fleks brand) was gently applied to the designated eye for 5 days.
Sponsors
Marmara University
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
28 Days to 18 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 28 days to 18 years * Receiving invasive mechanical ventilation * Admitted to the pediatric intensive care unit * Parent(s) or legal guardian(s) provide informed consent for participation
Exclusion criteria
-Having eye-related disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Ocular Dryness Score | Everyday for 5 days after the inclusion of participant | Ocular dryness will be measured using the Schirmer test.The score was compared between the eye treated with artificial tears and the eye treated with normal saline. |
| Occurence of Ocular Surface Disease | 1 time Everyday for 5 days after the inclusion of participant | Florescein testing will be used to evaluate the development of ocular surface disease |
| Change in Eyelid Closure Degree | 1 time everyday for 5 days after the inclusion of participant | Eyelid Closure Degree was evaluated by clinical observation and scoring (e.g., staining intensity and affected area). The score was compared between the eye treated with artificial tears and the eye treated with normal saline. |
Countries
Turkey (Türkiye)
Outcome results
None listed